Literature DB >> 18761033

Species specialization in cytokine biology: is interleukin-4 central to the T(H)1-T(H)2 paradigm in swine?

Michael P Murtaugh1, Craig R Johnson, Zhengguo Xiao, Ronald W Scamurra, Yaling Zhou.   

Abstract

The TH1-TH2 paradigm provides an elegant model of directed response to infectious pathogens. Developed in the mouse, the model has provided a framework for systematic and mechanistic studies of immune regulation, protective immunity, and vaccine development in swine. Interleukin-4 (IL-4) plays a central role in the paradigm as a regulatory molecule directing development of the TH2 phenotype, as a developmental cytokine essential for antibody production, and as a soluble diagnostic marker of the TH2 cell type. In contrast, while characterizing the biological properties of porcine IL-4, we discovered that it was not a stimulatory factor for porcine B cells. Rather, it blocked antibody and IL-6 secretion and suppressed antigen-stimulated proliferation of B cells. Inhibition was not reversed by treatment with IL-2 and IL-6 treatment. IL-4 did not stimulate T lymphocyte proliferation, but induced cell growth in lymphoblasts in a dose-dependent fashion. These results suggest that IL-4 plays a different role in pigs than in mice and humans, in which it stimulates B cells and is essential for antibody production. Furthermore, the functions of IL-4 in swine cannot be inferred from results in model systems such as the mouse. General models of disease resistance show substantial variation between pigs and mice at the cellular and molecular level. Advances in somatic cell technologies and animal engineering to enable gene knockouts in pigs, in combination with a continuously expanding immunological toolkit, promise an exciting future for pig immunology, detailed mechanistic elucidation of the TH1-TH2 paradigm, and an improved understanding of the role of IL-4 in porcine immunity to infectious disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761033     DOI: 10.1016/j.dci.2008.06.014

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  27 in total

1.  Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.

Authors:  Qing Lan; Sophia S Wang; Idan Menashe; Bruce Armstrong; Yawei Zhang; Patricia Hartge; Mark P Purdue; Theodore R Holford; Lindsay M Morton; Anne Kricker; James R Cerhan; Andrew Grulich; Wendy Cozen; Shelia H Zahm; Meredith Yeager; Claire M Vajdic; Maryjean Schenk; Brian Leaderer; Jeff Yuenger; Richard K Severson; Nilanjan Chatterjee; Stephen J Chanock; Tongzhang Zheng; Nathaniel Rothman
Journal:  Br J Haematol       Date:  2011-03-21       Impact factor: 6.998

Review 2.  Use of platelet-rich fibrin in regenerative dentistry: a systematic review.

Authors:  Richard J Miron; Giovanni Zucchelli; Michael A Pikos; Maurice Salama; Samuel Lee; Vincent Guillemette; Masako Fujioka-Kobayashi; Mark Bishara; Yufeng Zhang; Hom-Lay Wang; Fatiha Chandad; Cleopatra Nacopoulos; Alain Simonpieri; Alexandre Amir Aalam; Pietro Felice; Gilberto Sammartino; Shahram Ghanaati; Maria A Hernandez; Joseph Choukroun
Journal:  Clin Oral Investig       Date:  2017-05-27       Impact factor: 3.573

Review 3.  Advances in swine immunology help move vaccine technology forward.

Authors:  Michael P Murtaugh
Journal:  Vet Immunol Immunopathol       Date:  2014-02-23       Impact factor: 2.046

4.  Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.

Authors:  Rajesh Singh; Shailesh Singh; Praveen K Sharma; Udai P Singh; David E Briles; Susan K Hollingshead; James W Lillard
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

5.  Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.

Authors:  Xiangdong Li; Amy Galliher-Beckley; Hongzhou Huang; Xiuzhi Sun; Jishu Shi
Journal:  Vaccine       Date:  2013-08-09       Impact factor: 3.641

6.  Fate of transgenic DNA from orally administered Bt MON810 maize and effects on immune response and growth in pigs.

Authors:  Maria C Walsh; Stefan G Buzoianu; Gillian E Gardiner; Mary C Rea; Eva Gelencsér; Anna Jánosi; Michelle M Epstein; R Paul Ross; Peadar G Lawlor
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

7.  Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions.

Authors:  Varun Dwivedi; Cordelia Manickam; Basavaraj Binjawadagi; Daniel Linhares; Michael P Murtaugh; Gourapura J Renukaradhya
Journal:  Virol J       Date:  2012-02-16       Impact factor: 4.099

8.  Cytokine profiles in pregnant gilts experimentally infected with porcine reproductive and respiratory syndrome virus and relationships with viral load and fetal outcome.

Authors:  Andrea Ladinig; Joan K Lunney; Carlos J H Souza; Carolyn Ashley; Graham Plastow; John C S Harding
Journal:  Vet Res       Date:  2014-12-06       Impact factor: 3.683

9.  Regulation of porcine plasmacytoid dendritic cells by cytokines.

Authors:  Nils Lannes; Artur Summerfield
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

Review 10.  A review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infection.

Authors:  Emma Lorenzen; Frank Follmann; Gregers Jungersen; Jørgen S Agerholm
Journal:  Vet Res       Date:  2015-09-28       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.